ODTX

Odyssey Therapeutics Inc Cross-source read$24.63 4.19%
Health CareCUSIP 67613T104· EOD Sep 11, 2026

Among active 13F managers last quarter, 26 opened and none reduced or exited; the largest holder to move was SR One Capital Management, LP (new position). Over the last 180 days, 7 insiders bought and 1 insider sold, a net +$75.3M in open-market trades.

Tracked 13F holders
34
13F value (tracked)
$585.6M
Smart-money readBullish
Net sellingNet buying
Funds · active managers, latest 13F
26 adding · 0 trimming
Insiders · Form 4 open-market, 180d
7 buying · 1 selling · +$75.3M
US House · STOCK Act, 180d
0 buying · 0 selling

Funds lean in and no leg opposes.

Price & smart-money activity

$24.63 4.19%0Y +36.8%
$14.50$18.33$22.16$25.99$29.82May 2026JunJunJulAugSep938
Hover for who · click for detailEnd-of-day closing prices52w $15.56 – $28.76

Who owns ODTX?

34 tracked 13F filers · ranked by shares held

34 tracked 13F filers disclose a position in ODTX as of the latest SEC 13F filings, a combined $585.6M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

#FundSharesPosition valueLast moveAs ofHistory
1FMR LLC5.2M
$96.9M
New
+5.2M sh
Q2 2026
2SR One Capital Management, LP3.8M
$71.0M
New
+3.8M sh
Q2 2026
3TPG GP A, LLC3.7M
$69.0M
New
+3.7M sh
Q2 2026
4Lightspeed Management Company, L.L.C.3.6M
$67.5M
New
+3.6M sh
Q2 2026
5Orbimed Advisors LLC3.0M
$56.2M
New
+3.0M sh
Q2 2026
6Sanofi2.0M
$37.3M
New
+2.0M sh
Q2 2026
7Deerfield Management Company, L.P.1.0M
$19.6M
New
+1.0M sh
Q2 2026
8Sands Capital Alternatives, LLC875K
$16.4M
New
+875K sh
Q2 2026
9HHLR Advisors, LTD.832K
$15.6M
New
+832K sh
Q2 2026
10General Catalyst Group Management, LLC810K
$15.2M
New
+810K sh
Q2 2026
11Vanguard Capital Management LLC720K
$13.5M
New
+720K sh
Q2 2026
12Foresite Capital Management V, LLC713K
$13.3M
New
+713K sh
Q2 2026
13Vivo Capital, LLC575K
$10.8M
New
+575K sh
Q2 2026
14EcoR1 Capital, LLC556K
$10.4M
New
+556K sh
Q2 2026
15Logos Global Management LP522K
$9.8M
New
+522K sh
Q2 2026
16Price T Rowe Associates Inc472K
$8.8M
New
+472K sh
Q2 2026
17Catalio Capital Management, LP458K
$8.6M
New
+458K sh
Q2 2026
18Redmile Group, LLC425K
$8.0M
New
+425K sh
Q2 2026
19Woodline Partners LP346K
$6.5M
New
+346K sh
Q2 2026
20Boxer Capital Management, LLC275K
$5.1M
New
+275K sh
Q2 2026
21BlackRock, Inc.241K
$4.5M
New
+241K sh
Q2 2026
22Citadel Advisors LLC222K
$4.2M
New
+222K sh
Q2 2026
23Siren, L.L.C.200K
$3.7M
New
+200K sh
Q2 2026
24Geode Capital Management, LLC189K
$3.5M
New
+189K sh
Q2 2026
25Cormorant Asset Management, LP175K
$3.3M
New
+175K sh
Q2 2026

Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

Is ODTX being bought or sold by institutions?

Last quarter, 26 funds opened a new position in ODTX, while none reduced or exited. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).

Opened
26
funds took a first position
Biggest moves · ranked by size of the change, positions above a floor

Funds that own ODTX also own

CompanyCo-held byTheir position there
Revolution Medicines IncRVMD13 funds$1.8B
Abivax Sa-ADRABVX13 funds$993.8M
Praxis Precision Medicines IPRAX12 funds$1.2B
Cogent Biosciences IncCOGT12 funds$748.0M
Dianthus Therapeutics IncDNTH12 funds$722.8M
Xenon Pharmaceuticals IncXENE12 funds$607.6M
Definium Therapeutics IncDFTX12 funds$559.5M
Erasca IncERAS11 funds$802.6M
Disc Medicine IncIRON11 funds$475.8M
Spyre Therapeutics IncSYRE11 funds$449.9M
Mineralys Therapeutics IncMLYS11 funds$387.2M
Structure Therapeutics IncGPCR11 funds$340.5M

Ranked by how many of ODTX's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in ODTX.

Insider activity (Form 4)

Full insider page →
Buys · 180d
$75.3M
7 insiders
Sells · 180d
$32K
1 insider
Net · 180d
$75.3M
12 open-market transactions
DateInsiderRoleActionSharesValue
May 11, 2026Chu ShelleyDirectorBuy (P)11K$200K
May 11, 2026Li Nan (LN)DirectorBuy (P)1.1M$20.0M
May 11, 2026Sr One Capital Management, Llc10% OwnerSell (S)
3 lots, same day
2K$32K
May 11, 2026Sr One Capital Management, Llc10% OwnerBuy (P)
3 lots, same day
556K$10.0M
May 11, 2026Tpg Gp A, LlcInsiderBuy (P)1.4M$25.0M
May 8, 2026Leiden Jeffrey MDirectorBuy (P)5K$100K
May 8, 2026Haas JasonChief Financial OfficerBuy (P)1K$20K
May 8, 2026Dimension Capital II, L.P.DirectorBuy (P)1.1M$20.0M

One row per insider, day and transaction code; shares and value are summed across the lots. Every lot is on the full insider page and in the filing.

Do institutions, insiders and Congress agree?

Mixed signals

Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.

SEC EDGAR 13F + Form 4 + US House STOCK Act{ }get_ticker_confluence · API & MCP

Signals by source

Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive

SourceBuyingSellingNet
13F funds
Top 100 holders by value, passive included; the hero counts active managers only
00
Insiders
Form 4 open-market
71+$75.3M
US House
STOCK Act trades
00$0
Sector rotation
ODTX is in Health Care, which smart money is rotating OUT OF
$5.0B

Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.

Recent filings

15 most recent

Keep exploring

Connected entities for ODTX

Browse more

Build

Ask your agent what changed in ODTX

This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/stocks/ODTX/capital-change-brief"
Ask your agent
Use Arkolith's capital_change_brief for ODTX.
Tell me what changed, whether insider activity
corroborates it, and cite the SEC evidence.

13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for ODTX. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.